← Open Payments lookup

KATELYN PARR: Open Payments

NPI 1801513239 · WALDORF, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,759 in 80 payments from 30 companies in 2025. Trend: 2023 $0 · 2024 $1,525 · 2025 $1,759

Food & beverage: $1,759
CompanyPaymentsAmount
Lilly USA, LLC11$248
Xeris Pharmaceuticals, Inc.8$160
Novo Nordisk Inc10$149
SANOFI-AVENTIS U.S. LLC4$100
Boehringer Ingelheim Pharmaceuticals, Inc.4$98
Amgen Inc.4$79
Astellas Pharma US Inc3$75
Dexcom, Inc.2$60
RECORDATI_RARE_DISEASES_INC.3$57
Corcept Therapeutics2$56

Products named: MOUNJARO, JARDIANCE, TZIELD, RECORLEV, Ozempic, Veozah, GVOKE HYPOPEN, TEPEZZA.

Industry payments across MD — which companies pay providers there.